Peters, G. A. & Horton, B. T. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc. Staff. Meet. Mayo Clin. 26, 153–161 (1951).
Westergaard, M. L., Hansen, E. H., Glümer, C., Olesen, J. & Jensen, R. H. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia 34, 409–425 (2014).
Headache Classification Committee of the International Headache Society (IHS). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8, 1–96 (1988).
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38, 1–211 (2018).
Schwedt, T. J. et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J. Headache Pain 19, 38 (2018).
Bigal, M. E. et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48, 1157–1168 (2008).
Bigal, M. E., Rapoport, A. M., Sheftell, F. D., Tepper, S. J. & Lipton, R. B. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 24, 483–490 (2004).
Buse, D. C., Greisman, J. D., Baigi, K. & Lipton, R. B. Migraine progression: a systematic review. Headache 59, 306–338 (2019).
Hagen, K., Linde, M., Steiner, T. J., Stovner, L. J. & Zwart, J. A. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies. Pain 153, 56–61 (2012).
Ashina, H. & Dodick, D. W. Medication-overuse headache in patients with secondary headache disorders: need for revision? Headache 61, 790–791 (2021).
Zwart, J. A. et al. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 62, 1540–1544 (2004).
Young, W. B. De-stigmatizing migraine - with words. Headache 58, 319–321 (2018).
Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD). Institute for Health Metrics and Evaluation https://www.healthdata.org/gbd/2019 (2019).
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1545–1602 (2016).
Population Pyramid. Population pyramids of the World from 1950 to 2100. Population Pyramid https://www.populationpyramid.net (2019).
Luvsannorov, O. et al. Primary headache disorders among the adult population of Mongolia: prevalences and associations from a population-based survey. J. Headache Pain 20, 114 (2019).
Yu, S. et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52, 582–591 (2012).
Manandhar, K., Risal, A., Steiner, T. J., Holen, A. & Linde, M. The prevalence of primary headache disorders in Nepal: a nationwide population-based study. J. Headache Pain 16, 95 (2015).
Kulkarni, G. B., Rao, G. N., Gururaj, G., Stovner, L. J. & Steiner, T. J. Headache disorders and public ill-health in India: prevalence estimates in Karnataka State. J. Headache Pain 16, 67 (2015).
Ayzenberg, I. et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32, 373–381 (2012).
Rastenytė, D. et al. Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project. J. Headache Pain 18, 53 (2017).
Al Jumah, M. et al. The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study. J. Headache Pain 21, 11 (2020).
Herekar, A. A. et al. Primary headache disorders in the adult general population of Pakistan - a cross sectional nationwide prevalence survey. J. Headache Pain 18, 28 (2017).
Mbewe, E. et al. The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J. Headache Pain 16, 515 (2015).
Zebenigus, M., Tekle-Haimanot, R., Worku, D. K., Thomas, H. & Steiner, T. J. The prevalence of primary headache disorders in Ethiopia. J. Headache Pain 17, 110 (2016).
Stovner, L. J., Hagen, K., Linde, M. & Steiner, T. J. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J. Headache Pain 23, 34 (2022).
Zewde, Y. Z. et al. The prevalence of headache disorders in children and adolescents in Ethiopia: a schools-based study. J. Headache Pain 21, 108 (2020).
Togha, M. et al. The prevalence of headache disorders in children and adolescents in Iran: a schools-based study. Cephalalgia 42, 1246–1254 (2022).
Genc, D. et al. The prevalence of headache disorders in children and adolescents in Lithuania: a schools-based study. J. Headache Pain 21, 73 (2020).
Luvsannorov, O. et al. The prevalence of headache disorders in children and adolescents in Mongolia: a nationwide schools-based study. J. Headache Pain 21, 107 (2020).
Kawatu, N. et al. The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study. J. Headache Pain 23, 118 (2022).
Wöber-Bingöl, Ç. et al. The global burden of headache in children and adolescents-developing a questionnaire and methodology for a global study. J. Headache Pain 15, 86 (2014).
Westergaard, M. L., Glümer, C., Hansen, E. H. & Jensen, R. H. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain 155, 2005–2013 (2014).
Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T. & Jensen, R. H. Monitoring chronic headache and medication-overuse headache prevalence in Denmark. Cephalalgia 40, 6–18 (2020).
Jonsson, P., Hedenrud, T. & Linde, M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 31, 1015–1022 (2011).
Aaseth, K. et al. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia 28, 705–713 (2008).
Lampl, C. et al. Headache, depression and anxiety: associations in the Eurolight project. J. Headache Pain 17, 59 (2016).
Bendtsen, L. et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 34, 426–433 (2014).
Kristoffersen, E. S., Straand, J., Russell, M. B. & Lundqvist, C. Disability, anxiety and depression in patients with medication-overuse headache in primary care - the BIMOH study. Eur. J. Neurol. 23, 28–35 (2016).
Sarchielli, P. et al. Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. Eur. J. Neurol. 23, 85–91 (2016).
Vandenbussche, N. et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J. Headache Pain 19, 50 (2018).
Wang, Y.-F., Yu, C.-C., Kuan, A. S., Chen, S.-P. & Wang, S.-J. Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study. J. Headache Pain 22, 36 (2021).
Pakalnis, A., Butz, C., Splaingard, D., Kring, D. & Fong, J. Emotional problems and prevalence of medication overuse in pediatric chronic daily headache. J. Child Neurol. 22, 1356–1359 (2007).
Pompili, M. et al. Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr. Dis. Treat. 6, 81–91 (2010).
Bottiroli, S. et al. Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: a six-month follow-up of the COMOESTAS Project. Cephalalgia 39, 135–147 (2018).
Schwedt, T. J. et al. Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: results from the MOTS trial. Cephalalgia 41, 1053–1064 (2021).
Diener, H. C., Holle, D., Solbach, K. & Gaul, C. Medication-overuse headache: risk factors, pathophysiology and management. Nat. Rev. Neurol. 12, 575–583 (2016).
Viana, M. et al. Clinical subtypes of medication overuse headache - findings from a large cohort. Headache 59, 1481–1491 (2019).
Schwedt, T. J. et al. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache 61, 351–362 (2021).
Wang, S. J., Juang, K. D., Fuh, J. L. & Lu, S. R. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 68, 1468–1473 (2007).
Saylor, D. & Steiner, T. J. The global burden of headache. Semin. Neurol. 38, 182–190 (2018).
He, Z. et al. Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Eur. J. Neurol. 22, 1228–1234 (2015).
留言 (0)